ViiV Healthcare Company et al. v. Pharmascience Inc.

Call to arrange a consultation

2024

T-156-24

Pending

6(1) PMNOC

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,606,282 (dolutegravir).

Counsel to:

Pharmascience Inc.

The decision is reported

Partner

Partner

Associate